8664239

2 known cases. View patent page →

Veloxis Pharmaceuticals, Inc. v. Accord Healthcare, Inc. et al.

ongoing
Filed:
2022-07-07
Patents:8664239

This case was filed in response to Accord Healthcare's submission of an Abbreviated New Drug Application (ANDA) to the FDA, seeking approval to market generic versions of Veloxis's ENVARSUS XR prior to the expiration of several patents, including US 8664239. Veloxis alleges patent infringement, seeking to prevent the defendants from manufacturing their ANDA products and requesting damages if the products are launched.